Cardiol Therapeutics Inc. CRDL
We take great care to ensure that the data presented and summarized in this overview for Cardiol Therapeutics Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CRDL
View all-
Tejara Capital LTD London, X03.19MShares$4.47 Million1.2% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD982KShares$1.38 Million0.19% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9783KShares$1.1 Million0.35% of portfolio
-
Ubs Group Ag498KShares$696,9990.0% of portfolio
-
Pvg Asset Management Corp Golden, CO437KShares$612,3061.99% of portfolio
-
Lion Street Advisors, LLC334KShares$467,2140.11% of portfolio
-
Envestnet Asset Management Inc329KShares$460,8080.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.321KShares$449,7990.0% of portfolio
-
Atria Investments LLC Charlotte, NC139KShares$194,6740.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL100KShares$140,0000.06% of portfolio
Latest Institutional Activity in CRDL
Top Purchases
Top Sells
About CRDL
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx as a cardioprotective therapy to reduce cardiovascular and respiratory events in patients hospitalized with COVID-19, as well as to evaluate the efficacy and safety of CardiolRx in acute myocarditis. The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Insider Transactions at CRDL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|